LAWRENCE, Mass., June 3, 2015 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of
dialysis products, today announced data that home hemodialysis can
save California 221 million
gallons of water annually by transitioning just 20 percent of its
in-center dialysis patients to home hemodialysis with the NxStage®
System One™. Industry data shows conventional in-center
dialysis uses approximately 429 gallons of water per patient per
week, whereas home hemodialysis with the NxStage System One uses
only 30 gallons of water per patient per week.
The above infographic illustrates the dramatic impact home
hemodialysis with the System One can have on water consumption in
the state of California.
About the NxStage System One
The NxStage System One is
the first and only truly portable hemodialysis system cleared
specifically by the FDA for home hemodialysis and home
nocturnal hemodialysis. Its simplicity and revolutionary size (just
over a foot tall) are intended to allow convenient use in patients'
homes and give patients the freedom to travel with their therapy.
When combined with the NxStage PureFlow SL Dialysis Preparation
System, patients are able to further simplify, using ordinary tap
water to create dialysis fluid on demand. Unlike conventional
hemodialysis systems, the System One requires no special
infrastructure to operate. Under the guidance of their physician,
patients can use the NxStage System One, with their trained
partners, where, how and when it best meets their needs, including
while they are sleeping - at home or on vacation and at a medically
appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical
Inc. (Nasdaq: NXTM) is a medical device company, headquartered
in Lawrence, Massachusetts,
USA, that develops, manufactures and markets innovative
products for the treatment of ESRD and acute kidney failure. For
more information on NxStage and its products, please visit the
Company's website at www.nxstage.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the
quarter ended March 31, 2015. NxStage is under no obligation
to (and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Media contact:
Kristen K.
Sheppard, Esq.
ksheppard@nxstage.com
Tel: (978) 332-5923
Photo -
http://photos.prnewswire.com/prnh/20150603/220510-INFO
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/home-hemodialysis-with-nxstage-system-one-can-save-california-221-million-gallons-of-water-annually-300093376.html
SOURCE NxStage Medical, Inc.